| Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma PHD Nguyen, S Ma, CZJ Phua, NA Kaya, HLH Lai, CJ Lim, JQ Lim, ... Nature communications 12 (1), 227, 2021 | 94 | 2021 |
| Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial D Tai, K Loke, A Gogna, NA Kaya, SH Tan, T Hennedige, D Ng, F Irani, ... The Lancet Gastroenterology & Hepatology 6 (12), 1025-1035, 2021 | 62 | 2021 |
| Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma S Chuah, J Lee, Y Song, HD Kim, M Wasser, NA Kaya, K Bang, YJ Lee, ... Journal of hepatology 77 (3), 683-694, 2022 | 47 | 2022 |
| Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study W Zhai, H Lai, NA Kaya, J Chen, H Yang, B Lu, JQ Lim, S Ma, SC Chew, ... National science review 9 (3), nwab192, 2022 | 19 | 2022 |
| Obtaining spatially resolved tumor purity maps using deep multiple instance learning in a pan-cancer study MU Oner, J Chen, E Revkov, A James, SY Heng, AN Kaya, JJS Alvarez, ... Patterns 3 (2), 2022 | 13 | 2022 |
| Cell surface nucleolin is a novel ADAMTS5 receptor mediating endothelial cell apoptosis DC Kirman, B Renganathan, WK Chui, MW Chen, NA Kaya, R Ge Cell Death & Disease 13 (2), 172, 2022 | 8 | 2022 |
| Genome instability is associated with ethnic differences between Asians and Europeans in hepatocellular carcinoma NA Kaya, J Chen, H Lai, H Yang, L Ma, X Liu, JS Alvarez, J Liu, ... Theranostics 12 (10), 4703, 2022 | 3 | 2022 |
| Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma AJ Jeon, YY Teo, K Sekar, SL Chong, L Wu, SC Chew, J Chen, ... BMC cancer 23 (1), 118, 2023 | 2 | 2023 |
| A genomic enhancer signature associates with hepatocellular carcinoma prognosis AJ Jeon, CG Anene-Nzelu, YY Teo, SL Chong, K Sekar, L Wu, SC Chew, ... JHEP Reports 5 (6), 100715, 2023 | 1 | 2023 |
| Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma NA Kaya, D Tai, X Lim, JQ Lim, MC Lau, D Goh, CZJ Phua, FYT Wee, ... Journal for Immunotherapy of Cancer 11 (8), 2023 | 1 | 2023 |
| Tumor phylogeography reveals block-shaped spatial heterogeneity and the mode of evolution in Hepatocellular Carcinoma X Liu, K Zhang, NA Kaya, Z Jia, D Wu, T Chen, Z Liu, S Zhu, AM Hillmer, ... Nature Communications 15 (1), 3169, 2024 | | 2024 |
| Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment V Iakovleva, A Wuestefeld, ABL Ong, R Gao, NA Kaya, MY Lee, W Zhai, ... NPJ Regenerative Medicine 8 (1), 63, 2023 | | 2023 |
| 226P LongiBloodImmunoM: A multi-step analysis pipeline for longitudinal blood-based immunomonitoring for immunotherapy clinical trial J Ye, X Lim, KS Ng, NA Kaya, MC Lau, M Jia, CCL Cheung, HC Toh, ... Annals of Oncology 34, S271-S272, 2023 | | 2023 |
| An Integrative Analysis of Nasopharyngeal Carcinoma Genomes Unraveled Unique Processes Driving a Viral-Positive Cancer X Liu, Y Li, X Zhou, S Zhu, NA Kaya, YS Chan, L Ma, M Xu, W Zhai Cancers 15 (4), 1243, 2023 | | 2023 |
| 867 Deciphering of radiotherapy-induced immunomodulation effect synergized with immunotherapy in hepatocellular carcinoma by spatial multi-omics profiling MC Lau, L Suteja, L Cheung, J Lim, CJ Lim, X Lim, N Kaya, JF Ye, F Wee, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Author Correction: Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma PHD Nguyen, S Ma, CZJ Phua, NA Kaya, HLH Lai, CJ Lim, JQ Lim, ... Nature communications 12 (1), 1-1, 2021 | | 2021 |
| Resemblance of human cancer stem cells based on genome-wide expression profiles E Gov, N Kaya, KY Arga FEBS JOURNAL 283, 300-300, 2016 | | 2016 |
| A Phase II Trial of Y90-Resin Microspheres Radioembolization Followed by Nivolumab in Advanced Hepatocellular Carcinoma–CA 209-678 D Tai, K Loke, A Gogna, NA Kaya, SH Tan, T Hennedige, D Ng, F Irani, ... | | |
